Symbol="EVOK"
AssetType="Common Stock"
Name="Evoke Pharma Inc"
Description="Evoke Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of drugs for the treatment of gastroenterological diseases and disorders. The company is headquartered in Solana Beach, California."
CIK="1403708"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="420 STEVENS AVENUE, SUITE 370, SOLANA BEACH, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="4011700"
EBITDA="None"
PERatio="None"
PEGRatio="-0.1"
BookValue="0.161"
DividendPerShare="0"
DividendYield="0"
EPS="-2.42"
RevenuePerShareTTM="1.068"
ProfitMargin="-2.221"
OperatingMarginTTM="-2.118"
ReturnOnAssetsTTM="-0.404"
ReturnOnEquityTTM="-2.051"
RevenueTTM="3570200"
GrossProfitTTM="2138300"
DilutedEPSTTM="-2.42"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.45"
AnalystTargetPrice="7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3.048"
PriceToBookRatio="1.033"
EVToRevenue="0.0648"
EVToEBITDA="0.195"
Beta="0.332"
num_52WeekHigh="5.96"
num_52WeekLow="1.19"
num_50DayMovingAverage="1.573"
num_200DayMovingAverage="2.223"
SharesOutstanding="3343100"
DividendDate="None"
ExDividendDate="None"
symbol="EVOK"
open="1.21"
high="1.27"
low="1.12"
price="1.17"
volume="26968.00"
latest_trading_day="2023-08-21"
previous_close="1.22"
change="-0.05"
change_percent="-4.0984%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="23888"
Change_recent_avg="-0.02"
Delta_recent_avg="0.13"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-1.07"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="159"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0017.jpeg"
image_negative_thumbnail_id_2="131"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0045.jpeg"
image_neutral_thumbnail_id_1="549"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_neutral_thumbnail_id_2="582"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0017.jpeg"
image_positive_thumbnail_id_1="616"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0092.jpeg"
image_positive_thumbnail_id_2="992"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0154.jpeg"
image_professor_thumbnail_id_1="1188"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
image_professor_thumbnail_id_2="1177"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
